Leading AI companies restrict access to advanced models like GPT-Rosalind due to safety concerns.
3 results for: gpt-rosalind
OpenAI Launches GPT-Rosalind to Accelerate Life‑Sciences Research
OpenAI introduced GPT‑Rosalind, a frontier reasoning model aimed at speeding drug discovery, genomics, protein reasoning, and scientific workflows.
OpenAI Debuts GPT-Rosalind for Drug Discovery and Genomics
OpenAI launched GPT-Rosalind, its first life‑sciences model aimed at accelerating drug discovery and genomic analysis and cutting long development timelines.